Nikolaos Fragakis is an expert in Cardiology at Ippokrateio General Hospital of Thessaloniki (Greece). As of September 2026, ScienceLeadR ranks Nikolaos Fragakis in the top 1% of experts worldwide for Atrial Fibrillation and Arrhythmias, Cardiac. Nikolaos Fragakis has authored 299 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 5 of them ongoing. SLR score: 1,321 (community average: 125). How the SLR is computed.

LeadR Profile

1 321 ScienceLeadR Reputation 1321
Network Map

Cardiology

Subspecialties: Biochemistry - Endocrinology - Internal Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2001 - 2026

Source: PubMed

Aristotle University of Thessaloniki

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 299

Citations

Citations: 3 174 1st author: 29 Last author: 76 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Atrial Fibrillation Burden: Assessment, Clinical Significance, and Therapeutic Implications.
PMID 42653066 — atrial fibrillation, anti-arrhythmia agents, therapeutics, catheter ablation
Life (Basel)20260
Chronic Kidney Disease-Associated Cardiomyopathy: Mechanisms and Therapeutic Strategies.
PMID 42528432 — kidney diseases, hypertrophy, left ventricular, fibrosis, heart failure, heart failure, diastolic, hypertrophy, kidney, atrial fibrillation, therapeutics, cardiomyopathies
Br J Hosp Med (Lond)20260
Three-Dimensional Left Atrial Geometry in Atrial Fibrillation: Imaging Biomarkers, Substrate Phenotyping, and Ablation Outcome Prediction.
PMID 42510118 — atrial fibrillation, biomarkers, catheter ablation, artificial intelligence, anatomy, catheters, pulsed field ablation
Diagnostics (Basel)20260
True Left Bundle Branch Block by Strauss Criteria: Impact on CRT Response and Conduction System Pacing Trial Design-A Systematic Evidence Synthesis Toward Personalized Patient Selection.
PMID 42506113 — cardiac resynchronization therapy, bundle-branch block, cardiomyopathies
J Pers Med20260
Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: long-term outcomes from the PRESERVE EF study.
PMID 42490992 — myocardial infarction, predictive value of tests, risk factors
Front Cardiovasc Med20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 5
Phase 3 1
Phase 4 1

By status:

Recruiting 4
Completed 2
Not yet recruiting 1

By type:

Observational 5
Interventional 2

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 1
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Impact of Cardio Selective Beta Blockers on Infarct Size After Acute Myocardial Infarction
NCT07293832 — research design, hospitalization, myocardial infarction, st elevation myocardial infarction, echocardiography, therapeutics
N/ARecruiting2024
A Prospective Single center Observational Study Aiming to Assess the Predictive Role of Flow Mediated Dilatation in Acute Coronary Syndromes Combined With Echocardiographic and Biochemical Indices
NCT06890013 — research design, brachial artery, acute coronary syndrome, arteries, biomarkers, plasma
N/ARecruiting2024
Artificial Intelligence for Automated Clinical Data Exploration from Electronic Medical Records (CardioMining AI)
NCT05176769 — intelligence, electronic health records, machine learning, records, learning, artificial intelligence, medical records, electronic medical record, digital health
N/ARecruiting2022
Anticoagulation for Stroke Prevention In patients with Recent Episodes of Atrial Fibrillation occurring transiently with stress
2023-509142-35-00 — embolism, stroke, stress, physiological, hemorrhagic stroke, atrial fibrillation
Phase 4Recruiting2024
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
2023-505438-85-00 — safety, myocardial infarction, multiple chronic conditions, therapeutics, history
Phase 3Not yet recruiting2022

LeadR Networks

Main global connection map